Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.94
0.00 (0.00%)
Mar 9, 2026, 1:19 PM EDT - Market open
Immunocore Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 400.02 | 310.2 | 249.43 | 174.36 | 36.48 | Upgrade
|
| Revenue | 400.02 | 310.2 | 249.43 | 174.36 | 36.48 | Upgrade
|
| Revenue Growth (YoY) | 28.95% | 24.37% | 43.05% | 377.91% | -11.26% | Upgrade
|
| Cost of Revenue | 13.86 | 10.5 | 7.5 | 6.4 | 100.25 | Upgrade
|
| Gross Profit | 386.15 | 299.7 | 241.92 | 167.96 | -63.76 | Upgrade
|
| Selling, General & Admin | 165.41 | 155.78 | 144.5 | 123.06 | 110.82 | Upgrade
|
| Research & Development | 266.09 | 214.38 | 157.08 | 96.61 | - | Upgrade
|
| Other Operating Expenses | -19.73 | -18.05 | 0.9 | -0.01 | 0.07 | Upgrade
|
| Operating Expenses | 411.78 | 352.11 | 302.47 | 219.66 | 110.9 | Upgrade
|
| Operating Income | -25.63 | -52.41 | -60.55 | -51.7 | -174.66 | Upgrade
|
| Interest Expense | -12.17 | -18.84 | -5.15 | -5.41 | -5.57 | Upgrade
|
| Interest & Investment Income | 16.48 | 25.62 | 17.99 | 3.76 | 0.07 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.22 | -3.45 | -13.18 | 14.16 | 0.29 | Upgrade
|
| EBT Excluding Unusual Items | -19.1 | -49.08 | -60.89 | -39.2 | -179.88 | Upgrade
|
| Other Unusual Items | - | -3.85 | - | -1.69 | - | Upgrade
|
| Pretax Income | -19.1 | -52.94 | -60.89 | -40.88 | -179.88 | Upgrade
|
| Income Tax Expense | 16.41 | -1.85 | -5.6 | 11.66 | 0.15 | Upgrade
|
| Net Income | -35.51 | -51.09 | -55.29 | -52.54 | -180.03 | Upgrade
|
| Net Income to Common | -35.51 | -51.09 | -55.29 | -52.54 | -180.03 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 50 | 49 | 46 | 42 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 50 | 49 | 46 | 42 | Upgrade
|
| Shares Change (YoY) | 0.71% | 2.25% | 6.94% | 7.59% | 60.19% | Upgrade
|
| EPS (Basic) | -0.71 | -1.02 | -1.13 | -1.15 | -4.24 | Upgrade
|
| EPS (Diluted) | -0.71 | -1.02 | -1.13 | -1.15 | -4.24 | Upgrade
|
| Free Cash Flow | -15.05 | 20.89 | -2.49 | -51.41 | -144.49 | Upgrade
|
| Free Cash Flow Per Share | -0.30 | 0.42 | -0.05 | -1.13 | -3.40 | Upgrade
|
| Gross Margin | 96.53% | 96.61% | 96.99% | 96.33% | -174.77% | Upgrade
|
| Operating Margin | -6.41% | -16.89% | -24.27% | -29.65% | -478.73% | Upgrade
|
| Profit Margin | -8.88% | -16.47% | -22.17% | -30.14% | -493.45% | Upgrade
|
| Free Cash Flow Margin | -3.76% | 6.73% | -1.00% | -29.49% | -396.04% | Upgrade
|
| EBITDA | -22.36 | -48.21 | -56.46 | -46.37 | -167.07 | Upgrade
|
| EBITDA Margin | -5.59% | -15.54% | -22.63% | -26.59% | - | Upgrade
|
| D&A For EBITDA | 3.27 | 4.2 | 4.09 | 5.34 | 7.59 | Upgrade
|
| EBIT | -25.63 | -52.41 | -60.55 | -51.7 | -174.66 | Upgrade
|
| EBIT Margin | -6.41% | -16.89% | -24.27% | -29.65% | - | Upgrade
|
| Revenue as Reported | 400.02 | 310.2 | 249.43 | 174.36 | 36.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.